Skip to main content
Sartorius Stedim Biotech logo

Sartorius Stedim Biotech — Investor Relations & Filings

Ticker · DIM ISIN · FR0013154002 LEI · 52990006IVXY7GCSSR39 PA Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-11-03 Declaration of Voting R…
Country FR France
Listing PA DIM

About Sartorius Stedim Biotech

https://www.sartorius.com/en

Sartorius Stedim Biotech is a leading international provider of equipment and services for the biopharmaceutical industry. The company offers integrated solutions that support the entire lifecycle of drug development and manufacturing, from research and development to quality assurance and commercial production. Its comprehensive portfolio includes technologies for filtration, fluid management, fermentation, cell culture, and purification. Key products encompass bioreactors, single-use systems, process filtration equipment, cell culture media, and data analytics software. Sartorius Stedim Biotech enables its customers to develop and manufacture biotech medications, including cell and gene therapies, more efficiently and safely, helping to accelerate the translation of scientific discoveries into patient care.

Recent filings

Filing Released Lang Actions
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal declaration regarding the number of shares and voting rights of Sartorius Stedim Biotech S.A., citing Article L 233-8-II of the French Commercial Code and Article 223-6 of the AMF General Regulation. This type of disclosure is a standard regulatory requirement for listed companies to report their capital structure and voting rights, which falls under the category of regulatory filings or specific share capital disclosures. Given the provided categories, 'RNS' (Regulatory Filings) is the most appropriate classification for this type of mandatory regulatory disclosure.
2025-11-03 French
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal declaration of the total number of shares and voting rights for Sartorius Stedim Biotech SA, as required by French commercial law (Article L 233-8-II). While it provides specific share capital data, it is a standard regulatory disclosure announcement rather than a major shareholding notification (which tracks individual investors) or a share issue announcement (which details new capital raises). Given it is a routine regulatory disclosure of capital structure, it falls under the 'Regulatory Filings' category.
2025-11-03 English
Sartorius Stedim Biotech publie ses résultats non audités pour les neuf premiers mois de l’année 2025
Earnings Release Classification · 1% confidence The document is a press release from Sartorius Stedim Biotech announcing its non-audited financial results for the first nine months of 2025. It provides key financial highlights, performance metrics, and updated guidance for the full year. While it contains financial data, it is structured as an initial announcement of quarterly/periodical results rather than a full comprehensive interim report or a regulatory filing. Therefore, it fits the definition of an Earnings Release (ER). 9M 2025
2025-10-16 French
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
Earnings Release Classification · 1% confidence The document is a media release announcing the unaudited financial results for the first nine months of 2025. It provides key highlights, management commentary, and financial tables. While it contains financial data, it is structured as a press release (indicated by the 'News Details' header, contact information, and the 'Dissemination of a Financial Wire News' footer). It is not the full interim report itself, but rather an announcement of the results, which fits the definition of an Earnings Release (ER). 9M 2025
2025-10-16 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Share Issue/Capital Change Classification · 1% confidence The document is a formal declaration regarding the number of shares and voting rights of Sartorius Stedim Biotech S.A. It explicitly references Article L 233-8-II of the French Commercial Code and Article 223-6 of the AMF General Regulation, which are standard regulatory requirements for disclosing share capital and voting rights. This type of disclosure is a standard regulatory filing in France and does not fit into specific categories like dividend announcements or director dealings.
2025-10-06 French
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Share Issue/Capital Change Classification · 1% confidence The document is a formal declaration of the total number of shares and voting rights for Sartorius Stedim Biotech S.A., citing Article L 233-8-II of the French Code of commerce. This type of disclosure is a standard regulatory requirement for listed companies to update the market on their capital structure and voting rights, which falls under the category of regulatory filings for share capital and voting rights.
2025-10-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.